View in EDS

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group Study.

Saved in:
Bibliographic Details
Title: Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group Study.
Authors: Chow V; Amgen Inc., Thousand Oaks, CA, USA., Winkle PJ; Anaheim Clinical Trials, Anaheim, CA, USA., Mytych DT; Amgen Inc., Thousand Oaks, CA, USA., Cao J; Amgen Inc., Thousand Oaks, CA, USA., Barragan C; Amgen Inc., Thousand Oaks, CA, USA., Colbert A; Amgen Inc., Thousand Oaks, CA, USA., Gupta S; Amgen Inc., Thousand Oaks, CA, USA., Radziszewski W; Amgen Inc., Thousand Oaks, CA, USA., Franklin J; Amgen Inc., Thousand Oaks, CA, USA.
Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2026 Feb; Vol. 15 (2), pp. e70031.
Publication Type: Journal Article; Randomized Controlled Trial; Comparative Study
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41641897
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chow+V%22">Chow V</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Winkle+PJ%22">Winkle PJ</searchLink>; Anaheim Clinical Trials, Anaheim, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mytych+DT%22">Mytych DT</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cao+J%22">Cao J</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Barragan+C%22">Barragan C</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Colbert+A%22">Colbert A</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Radziszewski+W%22">Radziszewski W</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Franklin+J%22">Franklin J</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572899%22">Clinical pharmacology in drug development</searchLink> [Clin Pharmacol Drug Dev] 2026 Feb; Vol. 15 (2), pp. e70031.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572899 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2160-7648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222160763X%22">2160763X </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Drug Dev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41641897
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpdd.70031
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70031
    Titles:
      – TitleFull: Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open-Label, Parallel-Group Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chow V
      – PersonEntity:
          Name:
            NameFull: Winkle PJ
      – PersonEntity:
          Name:
            NameFull: Mytych DT
      – PersonEntity:
          Name:
            NameFull: Cao J
      – PersonEntity:
          Name:
            NameFull: Barragan C
      – PersonEntity:
          Name:
            NameFull: Colbert A
      – PersonEntity:
          Name:
            NameFull: Gupta S
      – PersonEntity:
          Name:
            NameFull: Radziszewski W
      – PersonEntity:
          Name:
            NameFull: Franklin J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2160-7648
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical pharmacology in drug development
              Type: main
ResultId 1